JPS6187622A - 抗リウマチ座薬とその製造法 - Google Patents

抗リウマチ座薬とその製造法

Info

Publication number
JPS6187622A
JPS6187622A JP60212743A JP21274385A JPS6187622A JP S6187622 A JPS6187622 A JP S6187622A JP 60212743 A JP60212743 A JP 60212743A JP 21274385 A JP21274385 A JP 21274385A JP S6187622 A JPS6187622 A JP S6187622A
Authority
JP
Japan
Prior art keywords
suppository
isoxicam
base
general formula
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60212743A
Other languages
English (en)
Japanese (ja)
Inventor
アドルフ・クネヒト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of JPS6187622A publication Critical patent/JPS6187622A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP60212743A 1984-09-29 1985-09-27 抗リウマチ座薬とその製造法 Pending JPS6187622A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843435843 DE3435843A1 (de) 1984-09-29 1984-09-29 Antirheumatisch wirksame suppositorien
DE3435843.9 1984-09-29

Publications (1)

Publication Number Publication Date
JPS6187622A true JPS6187622A (ja) 1986-05-06

Family

ID=6246720

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60212743A Pending JPS6187622A (ja) 1984-09-29 1985-09-27 抗リウマチ座薬とその製造法

Country Status (5)

Country Link
US (1) US4612310A (en, 2012)
EP (1) EP0177853B1 (en, 2012)
JP (1) JPS6187622A (en, 2012)
AT (1) ATE44458T1 (en, 2012)
DE (2) DE3435843A1 (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents
DE19512710A1 (de) * 1995-04-10 1996-10-17 Behringwerke Ag Biosensor
AU675391B2 (en) * 1995-06-26 1997-01-30 Proviron Property Services Pty Ltd Floating debris collection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE3571392D1 (en) 1989-08-17
EP0177853A2 (de) 1986-04-16
EP0177853B1 (de) 1989-07-12
DE3435843A1 (de) 1986-04-03
ATE44458T1 (de) 1989-07-15
DE3435843C2 (en, 2012) 1988-10-27
US4612310A (en) 1986-09-16
EP0177853A3 (en) 1986-12-17

Similar Documents

Publication Publication Date Title
CA1177398A (en) Watersoluble derivatives of non-steroidal anti- inflammatory agents and a process for the production thereof
KR930000861B1 (ko) 오메프라졸 직장투여 조성물
KR101235102B1 (ko) 플리반세린을 포함하는 성욕 장애 치료용 약제학적 조성물
US6491950B1 (en) Controlled release pharmaceutical composition
EP2084165B1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
ES2230608T3 (es) Composicion farmaceutica destinada a una administracion por via oral.
JP2002510329A (ja) 親油性化合物用の自己乳化性処方
EP0287341B1 (en) Rectally absorbable form of l-dopa
ES2574831T3 (es) Inhibidores de la proteasa antivirales
EA017763B1 (ru) Фармацевтический вагинальный гель
KR20000015778A (ko) 로제시아 치료제_
CN110437205A (zh) 吡啶烯基哌啶衍生物及其用途
JPS6321648B2 (en, 2012)
CN116496205B (zh) 一种卡瑞斯汀的盐及其用途
AU2004238537A1 (en) Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
JPS6187622A (ja) 抗リウマチ座薬とその製造法
JP3276762B2 (ja) イソキノリン誘導体を含有する医薬組成物
JPH0361644B2 (en, 2012)
JPH02138123A (ja) 心不全治療用医薬組成物
ITRM940322A1 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione".
CN105367472A (zh) 吲哚啉类衍生物及其在药物上的应用
CN109734712A (zh) 芳基或杂芳基取代的吡咯烷酰胺衍生物及其用途
US20060173028A1 (en) Therapeutic and/or preventive agent for chronic skin disease
KR20010032194A (ko) 피리돈카르복실을 용해시키는 방법, 이 산을 용해시키는용해제, 이 산을 함유하는 수용액 제제, 및 이를 제조하는방법
JPH10236952A (ja) 安定な医薬組成物